Navigation Links
Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
Date:6/1/2011

HOPKINTON, Mass., June 1, 2011 /PRNewswire/ -- Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life sciences research, hosted its 2011 annual Customers Owners Group (COG 2011) meeting on May 17 and 18 at its Hopkinton headquarters. This thought-leadership conference brought together leaders in research, drug discovery, and diagnostics to discuss the technologies and discoveries that are transforming the detection and treatment of disease, and making personalized medicine a reality. More than 350 customers attended the event, which featured 45 presentations from researchers representing life sciences companies and institutions.

"COG 2011 was a tremendous congress, with presentation tracks focused on next generation sequencing, imaging & pathology, biomarkers discovery, molecular diagnostics, biologics & vaccines, and targeted small molecules, each of which is a critical enabling theme for personalized medicine. A key message from the meeting was the clear need for technological innovations in these areas that can enable the precision diagnostics and therapeutics that are required to achieve the vision of personalized medicine," said Kevin Hrusovsky, President and CEO of Caliper Life Sciences. "This event highlighted Caliper's focus on innovation, collaboration, and culture as key cornerstones that define our efforts to extend and improve the quality of life and to truly place the patient first in the practice of medicine. Throughout the event, it was our privilege to motivate and provide inspiration to leading researchers from industry and academia, while also demonstrating how our technologies are having a profound impact on research applications."

"One of the main reasons I am here today is the important collaborations between academy and industry are going to drive this revolution. We are in an era of technology-driven medicine," said Dennis Ausiello, M.D., Chief of Medicine at Massachusetts General Hospital, Chief Scientific Officer of Partners Healthcare, and member of the Board of Directors of Pfizer and the Broad Institute, while delivering his keynote presentation about the advancements in research and technologies that will transform medicine. Dr. Ausiello cited specific examples where gene expression and sequencing technologies have improved the quality of patient care. "I am inspired personally by both the approach and the vision that Caliper has in helping deliver this revolution."

Additional keynote presentations were provided by Go van Dam, M.D., Ph.D., the pioneering surgeon and Associate Professor at University Medical Center Groningen, who presented on the innovative clinical application of optical imaging and biomarker detection technologies during surgical procedures to significantly improve a patient's prognosis, and by Stephan Schuster, Ph.D., Professor of Biochemistry and Molecular Biology, Pennsylvania State University and project leader for the South African Genome Project and the Wooly Mammoth Genome Project, who described the use of next generation sequencing to explore evolutionary diversity within mankind and of extinct and near-extinct organisms.

Caliper's vision for personalized medicine includes several enabling technology themes that will revolutionize the practice of healthcare in the near future. Caliper's COG events are organized into tracks that are closely aligned to these revolutionary themes: next generation sequencing, imaging and pathology, biomarkers discovery, molecular diagnostics, biologics and vaccines, and targeted small molecules.

Caliper extended its COG series, with upcoming events in Alameda, CA, USA on June 10, 2011 and in London, UK on September 14 and 15, 2011. For more details, and for presentations from previous COG events, please visit http://caliperls.com/support/caliper-owners-group.htm.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper is a registered trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences to Present at Jefferies 2011 Global Healthcare Conference
2. Caliper Life Sciences to Webcast Investor Session of Open House
3. Caliper Life Sciences Reports First Quarter 2011 Results
4. Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference
5. Caliper Life Sciences First Quarter Results Conference Call Notice
6. Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Caliper Life Sciences and HistoRx to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue
9. Analysis of Calipers Phase I EPA ToxCastâ„¢ Data Published in Leading Scientific Journal
10. Caliper and Covaris Establish Co-Marketing Agreement to Simplify Next Generation Sequencing
11. Caliper Life Sciences Fourth Quarter and Fiscal Year 2010 Financial Results Conference Call Notice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology:
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):